Azizi, M., Sharp, A. S. P., Fisher, N. D. L., Weber, M. A., Lobo, M. D., Daemen, J., Lurz, P., Mahfoud, F., Schmieder, R. E., Basile, J., Bloch, M. J., Saxena, M., Wang, Y., Sanghvi, K., Jenkins, J. S., Devireddy, C., Rader, F., Gosse, P., Claude, L., … Renkin, J. (2024). Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Circulation, 149(10), 747–759. https://doi.org/10.1161/circulationaha.123.066941

Bhatt, D. L., Vaduganathan, M., Kandzari, D. E., Leon, M. B., Rocha-Singh, K., Townsend, R. R., Katzen, B. T., Oparil, S., Brar, S., DeBruin, V., Fahy, M., Bakris, G. L., Bhatt, D. L., Bakris, G., Cohen, S. A., D’Agostino, R., Esler, M., Flack, J., Kandzari, D. E., … Zidar, F. (2022). Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. The Lancet, 400(10361), 1405–1416. https://doi.org/10.1016/s0140-6736(22)01787-1

Sanghvi, K., Wang, Y., Daemen, J., Mathur, A., Jain, A., Dohad, S., Sapoval, M., Azizi, M., Mahfoud, F., Lurz, P., Sayer, J., Levy, T., Zagoria, R., Loening, A. M., Coleman, L., Craig, D., Horesh-Bar, M., & Kirtane, A. J. (2022). Renal Artery Variations in Patients With Mild-to-Moderate Hypertension From the RADIANCE-HTN SOLO Trial. Cardiovascular Revascularization Medicine, 39, 58–65. https://doi.org/10.1016/j.carrev.2021.09.008